Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201210045 Principal Investigator: Stockerl-Goldstein, Keith
Title: Multicenter, Single-Arm, Open-Label Treatment Use Program For Pomalidomide (Pom) In Combination With Low Dose Dexamethasone (Ld-Dex) In Subjects With Relapsed Or Refractory Multiple Myeloma
Phase: N/A Disease Site: Multiple Myeloma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to provide pomalidomide to patients who have previously received at least 4 prior therapies for their myeloma while the medication is not commercially available, as well as to obtain safety and efficacy information (how well the drug works) based on a doctor’s assessment of whether or not the disease progresses while taking pomalidomide.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)